Nordic Vaccine's Asset Sale

Nordic Vaccine raised a round of funding on May 05, 2011. Investors include Isconova.

Nordic Vaccine is a vaccine research and development company, with focus on the development and commercialization of new vaccines for prophylactic and therapeutic use. …

Articles about Nordic Vaccine's Asset Sale: